Evidence map›Paper›PMID 31455382›Full record

ArticleStem cell research & therapy2019

Temporal and partial inhibition of GLI1 in neural stem cells (NSCs) results in the early maturation of NSC derived oligodendrocytes in vitro.

Poommaree Namchaiw, Han Wen, Florian Mayrhofer, Olga Chechneva, Sangita Biswas, Wenbin Deng

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Reporter Alleles in hiPSCs: Visual Cues on Development and Disease.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Poommaree NamchaiwDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA, USA.
Han WenDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA, USA.
Florian MayrhoferDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA, USA.
Olga ChechnevaDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA, USA.
Sangita BiswasDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA, USA. sangita.biswas@ucdmc.ucdavis.edu.ORCID 0000-0001-5879-6492
Wenbin DengDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA, USA. wbdeng@ucdavis.edu.
Shriners Hospitals for Children - Erie · USUniversity of California, Davis · USChinese Academy of Medical Sciences & Peking Union Medical College · CNSendai University · JP

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Differentiation and Integration of Trisomy 21 iPSCs in an Animal ModelR01HD091325 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TIAN, LIN · 2017 to 2021
$1.6M
Regenerating CNS white matter using induced pluripotent stem cellsR01HD087566 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DENG, WENBIN · 2016 to 2020
$1.5M
NCI NIH HHS P30 CA093373NICHD NIH HHS R01 HD087566NICHD NIH HHS R01 HD091325
6 · The paper itself

Abstract

backgroundOligodendrocytes are a type of glial cells that synthesize the myelin sheath around the axons and are critical for the nerve conduction in the CNS. Oligodendrocyte death and defects are the leading causes of several myelin disorders such as multiple sclerosis, progressive multifocal leukoencephalopathy, periventricular leukomalacia, and several leukodystrophies. Temporal activation of the Sonic Hedgehog (SHH) pathway is critical for the generation of oligodendrocyte progenitors, and their differentiation and maturation in the brain and spinal cord during embryonic development in mammals.

methodsOur protocol utilized adherent cultures of human induced pluripotent stem cells (iPSC) and human embryonic stem cells (hESCs) with a green fluorescent protein (GFP) reporter knocked into one allele of the OLIG2 gene locus, dual SMAD inhibition, and transient partial inhibition of glioma-associated oncogene 1 (GLI1) by the small molecule GANT61 during the formation of the SOX2/PAX6-positive neural stem cells (NSCs). The SHH pathway was later restimulated by a Smoothened agonist purmorphamine to induce the generation of OLIG2 glial precursors. One hundred ninety-two individual oligodendrocyte precursor cells (OPCs) from GANT61 and control group were analyzed by single-cell RNA sequencing (RNA-Seq).

resultsWe demonstrate here that transient and partial inhibition of the SHH pathway transcription factor GLI1 in NSCs by a small molecule inhibitor GANT61 was found to generate OPCs that were more migratory and could differentiate earlier toward myelin-producing oligodendrocytes. Single-cell transcriptomic analysis (RNA-Seq) showed that GANT61-NSC-derived oligodendrocyte precursor cells (OPCs) had differential activation of some of the genes in the cytoskeleton rearrangement pathways that are involved in OPC motility and induction of maturation. At the protein level, this was also associated with higher levels of myelin-specific genes in the GANT61 group compared to controls. GANT61-NSC-derived OPCs were functional and could generate compact myelin in vitro and in vivo after transplantation in myelin-deficient shiverer mice.

conclusionsThis is a small molecule-based in vitro protocol that leads to the faster generation of functional oligodendrocytes. The development of protocols that lead to efficient and faster differentiation of oligodendrocytes from progenitors provides important advances toward the development of autologous neural stem cell-based therapies using human iPSCs.

Indexed as

AnimalsAxonsCell DifferentiationCells, CulturedFemaleHedgehog ProteinsHumansInduced Pluripotent Stem CellsMaleMiceMyelin SheathNeural Stem CellsNeuronsOligodendrocyte Transcription Factor 2OligodendrogliaPyridinesGANT 61GLI1 protein, humanHedgehog ProteinsOligodendrocyte Transcription Factor 2PyridinesPyrimidinesZinc Finger Protein GLI1DifferentiationGANT61GLI1hESChiPSCMyelinationNSCOligodendrocyteOPCRNA-SeqSHHSmall moleculeSonic Hedgehog

Identifiers

PMID31455382
PMCPMC6712625
OpenAlexW2970719648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.